AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 40 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,299,033 | +5.1% | 557,525 | +7.3% | 0.00% | – |
Q2 2023 | $1,236,272 | +37.9% | 519,442 | +6.6% | 0.00% | – |
Q1 2023 | $896,759 | +25.6% | 487,369 | +29.7% | 0.00% | – |
Q4 2022 | $713,756 | -14.4% | 375,661 | -3.6% | 0.00% | – |
Q3 2022 | $834,000 | -19.0% | 389,839 | +7.1% | 0.00% | – |
Q2 2022 | $1,030,000 | +3.0% | 363,955 | +51.9% | 0.00% | – |
Q1 2022 | $1,000,000 | -3.2% | 239,635 | +20.3% | 0.00% | – |
Q4 2021 | $1,033,000 | -37.8% | 199,173 | -21.4% | 0.00% | – |
Q3 2021 | $1,660,000 | +74.7% | 253,430 | +77.2% | 0.00% | – |
Q2 2021 | $950,000 | +136.9% | 143,004 | +103.9% | 0.00% | – |
Q1 2021 | $401,000 | +67.8% | 70,136 | +161.9% | 0.00% | – |
Q4 2020 | $239,000 | +25.1% | 26,775 | +62.4% | 0.00% | – |
Q3 2020 | $191,000 | -4.5% | 16,483 | +32.1% | 0.00% | – |
Q2 2020 | $200,000 | +124.7% | 12,476 | -16.4% | 0.00% | – |
Q1 2020 | $89,000 | +270.8% | 14,921 | +728.0% | 0.00% | – |
Q4 2019 | $24,000 | -11.1% | 1,802 | -18.2% | 0.00% | – |
Q3 2019 | $27,000 | +145.5% | 2,202 | +214.6% | 0.00% | – |
Q2 2019 | $11,000 | +22.2% | 700 | +133.3% | 0.00% | – |
Q1 2019 | $9,000 | -50.0% | 300 | -45.5% | 0.00% | – |
Q4 2018 | $18,000 | -48.6% | 550 | -52.2% | 0.00% | – |
Q3 2018 | $35,000 | +400.0% | 1,150 | +360.0% | 0.00% | – |
Q2 2018 | $7,000 | – | 250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |